Quidel Corporation (QDEL): Price and Financial Metrics

Quidel Corporation (QDEL)

Today's Latest Price: $97.81 USD

0.00 (0.00%)

Updated Apr 1 6:55pm

Add QDEL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

QDEL Stock Summary

  • With a one year PEG ratio of 1,003.35, Quidel Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 97.11% of US stocks.
  • QDEL's current price/earnings ratio is 49.22, which is higher than 90.28% of US stocks with positive earnings.
  • The price/operating cash flow metric for Quidel Corp is higher than 90.24% of stocks in our set with a positive cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Quidel Corp are APPF, MJCO, DHX, VNDA, and SLP.
  • Visit QDEL's SEC page to see the company's official filings. To visit the company's web site, go to www.quidel.com.
QDEL Daily Price Range
QDEL 52-Week Price Range

QDEL Stock Price Chart More Charts

QDEL Price/Volume Stats

Current price $97.81 52-week high $106.56
Prev. close $97.81 52-week low $52.49
Day low $92.76 Volume 596,900
Day high $103.00 Avg. volume 432,144
50-day MA $82.42 Dividend yield N/A
200-day MA $68.13 Market Cap 4.10B

Quidel Corporation (QDEL) Company Bio

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, women’s health, and gastrointestinal diseases. The company was founded in 1979 and is based in San Diego, California.

QDEL Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for Quidel Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Quidel Corp ranked in the 68th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. In terms of the factors that were most noteworthy in this DCF analysis for QDEL, they are:

  • In the past 5.31 years, Quidel Corp has a compound free cash flow growth rate of 0.71%; that's higher than 86.21% of free cash flow generating stocks in the Healthcare sector.
  • 97% of the company's capital comes from equity, which is greater than 91.49% of stocks in our cash flow based forecasting set.
  • The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately only 8.47% of US stocks with free cash flow have a lower reliance on debt in their capital structure.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Quidel Corp? See ABBV, FMS, RSCF, SEM, and AMN.

QDEL Latest News Stream

Event/TimeNews Detail
Loading, please wait...

QDEL Latest Social Stream

Loading social stream, please wait...

View Full QDEL Social Stream

QDEL Price Returns

1-mo 22.58%
3-mo 31.27%
6-mo 64.89%
1-year 52.40%
3-year 328.62%
5-year 278.52%
YTD 30.36%
2019 53.69%
2018 12.62%
2017 102.38%
2016 1.04%
2015 -26.69%

Continue Researching QDEL

Here are a few links from around the web to help you further your research on Quidel Corp's stock as an investment opportunity:

Quidel Corp (QDEL) Stock Price | Nasdaq
Quidel Corp (QDEL) Stock Quote, History and News - Yahoo Finance
Quidel Corp (QDEL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8518 seconds.